posted on 2023-03-30, 22:21authored byGunnar Steinert, Sebastian Schölch, Thomas Niemietz, Naoki Iwata, Sebastián A. García, Bianca Behrens, Anita Voigt, Matthias Kloor, Axel Benner, Ulrich Bork, Nuh N. Rahbari, Markus W. Büchler, Nikolas H. Stoecklein, Jürgen Weitz, Moritz Koch
<p>PDF file - 96KB, Summary of patient characteristics and number of chromosomal aberrations determined by aCGH analyses (S1); Summary of the full genomic analyses of CRC derived CTC and the corresponding tumor tissue (S2); UICC stages of the patients enrolled in the mutational analysis (S3); Characteristics of the patients enrolled in the CTC transcriptional analysis (S4); Distribution of sex and UICC stage in patients enrolled in the CTC transcriptional analysis (S5); Summary of patient characteristics and source of CTC isolation for the CTC transcriptional analysis (S6); Clinical information regarding patients enrolled in the CTC mutational analysis (S7); Overview of the real-time PCR primer sequences used in the CTC transcriptional analysis (S8); Overview of the pre-amplification PCR primer sequences used for the mutational profiling of patient-derived CTC and tumor tissue (S9); Summary of the primer sequences used for sequencing analyses and detection of common CRC mutation (S10); Summary of the primer sequences used for noncoding and coding MSI analyses (S11).</p>